| pubmed-article:10094322 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C0041327 | lld:lifeskim |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C1517942 | lld:lifeskim |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C0205269 | lld:lifeskim |
| pubmed-article:10094322 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:10094322 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:10094322 | pubmed:dateCreated | 1999-4-30 | lld:pubmed |
| pubmed-article:10094322 | pubmed:abstractText | Multidrug-resistant tuberculosis patients without human immunodeficiency virus (HIV) infection, with Mycobacterium tuberculosis resistant to almost all of the available drugs. | lld:pubmed |
| pubmed-article:10094322 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10094322 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10094322 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10094322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10094322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10094322 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10094322 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10094322 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:10094322 | pubmed:issn | 1027-3719 | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:AbbatiAA | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:González... | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:RendoPP | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:EiguchiKK | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:PalmeroDD | lld:pubmed |
| pubmed-article:10094322 | pubmed:author | pubmed-author:Castro... | lld:pubmed |
| pubmed-article:10094322 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10094322 | pubmed:volume | 3 | lld:pubmed |
| pubmed-article:10094322 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10094322 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10094322 | pubmed:pagination | 214-8 | lld:pubmed |
| pubmed-article:10094322 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:meshHeading | pubmed-meshheading:10094322... | lld:pubmed |
| pubmed-article:10094322 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10094322 | pubmed:articleTitle | Phase II trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. | lld:pubmed |
| pubmed-article:10094322 | pubmed:affiliation | Institute of Pulmonary Diseases, University of Buenos Aires, Argentina. | lld:pubmed |
| pubmed-article:10094322 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10094322 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10094322 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10094322 | lld:pubmed |
